Moderna shipped 800 million COVID vaccines last year, more than tripled its cash position but stock falls again

Moderna Inc. MRNA, -7.45% said successful a missive to shareholders disclosed Tuesday, Chief Executive Stéphane Bancel said the biotechnology institution had shipped astir 800 cardinal doses of its COVID-19 vaccine to much than 60 countries successful 2021, and much than tripled the magnitude of currency and currency equivalents it held. Meanwhile, the banal dropped 1.2% successful premarket trading, aft dropping 7.5% connected Monday, and tumbling 27.9% successful December. Bancel said the institution had much than $17 cardinal successful currency and currency equivalents astatine the extremity of 2021, aft entering the twelvemonth with astir $5.25 billion. The institution said it was moving with the U.S. Food and Drug Administration to person its COVID-19 vaccine authorized for 12 to 17 twelvemonth olds, arsenic it is already authorized successful much than 10 countries and the European Union. Separately, Bancel said Moderna's flu vaccine has showed "positive" interim Phase 1 data, its vaccine for respiratory syncytial microorganism (RSV) moved to a Phase 2/3 proceedings and that its Personalized Cancer Vaccine Phase 2 proceedings is afloat enrolled with a readout expected arsenic aboriginal arsenic the 4th fourth of 2022. The banal has dropped 27.9% implicit the past 3 months done Monday, but was inactive up 110.4% implicit the past 12 months, portion the S&P 500 SPX, +0.64% has gained 11.5% the past 3 months and rallied 29.6% the past year.